Connection

Theodore Gourdin to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Theodore Gourdin has written about Protein Kinase Inhibitors.
Theodore Gourdin
Connection Strength
0.138
Protein Kinase Inhibitors
  1. Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials. J Oncol Pharm Pract. 2020 Jun; 26(4):861-865.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.